Retatrutide is a newly developed medication that acts as a strong GLP-1 receptor stimulator. This innovative approach holds significant potential for managing type 2 diabetes. By replicating the actions of natural GLP-1, Retatrutide boosts insulin secretion and suppresses glucagon release, leading to improved blood sugar control. Clinical trials ha